The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Insulin Aspart (Novorapid Flexpen Vial) is a fast ...
Insulin Aspart (Novorapid Penfill (100 iu)) is a fast-acting form of the hormone insulin, prescribed for diabetes mellitus. It is used with other medium- or long-acting insulin products injected just ...
Bagsværd, Denmark, 4 December 2015 - Novo Nordisk today announced the submission to the European Medicines Agency of the Marketing Authorisation Application (MAA) for the approval of faster-acting ...
The FINANCIAL — Novo Nordisk on September 16 announced that the Committee for Medicinal Products for Human Use, CHMP, has adopted a positive opinion to extend the use of NovoRapid (insulin aspart) in ...
Faster-acting insulin aspart improved postprandial glucose (PPG) control in type 1 and type 2 diabetes New phase 3a findings showed that faster-acting insulin aspart demonstrated a statistically ...
NEW ORLEANS — In this video exclusive, Bruce W. Bode, MD, FACE, president of Atlanta Diabetes Associates, discusses results of the phase 3a Onset clinical trials of faster-acting insulin aspart (Novo ...
Bagsværd, Denmark, 25 March 2015 - Novo Nordisk today announced headline results from the final phase 3a trials for faster-acting insulin aspart, onset ® 1 and onset ® 2. The trials investigated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results